Kayla Garrett: Improving Haemophilia A Care Beyond Bleed Prevention
Kayla Garrett, Senior Talent Acquisition Partner at Roche, shared a post on LinkedIn:
“At the heart of every discussion about the future of haemophilia A is the recognition that redefining care goes beyond medicine – it is about looking at patients’ whole lives, protecting joint health, and easing the daily anxieties that families carry across generations.
At Roche, we believe that even one bleed is one too many, especially for a condition like haemophilia A that is for life.
We are profoundly grateful to the dedicated clinicians, researchers, and patient organisations who partner with us every day.
Together, we are raising the bar to turn scientific progress into a new reality.
Find out more about our efforts in haemophilia A on our website.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 17, 2026, 15:22α2-Antiplasmin Inhibition and the Future of Thrombolysis
-
Sep 17, 2026, 15:20Fatma M. Attia: Expanding the Evidence Base for Therapeutic Plasma Exchange Across Multiple Indications
-
Sep 17, 2026, 15:19Conan McIlwrath: The Haemophilia Society Engages With IBCA
-
Sep 17, 2026, 15:06Eleftheria Hatzimichael: A Contemporary Diagnostic Approach to Inherited Microcytic Anemias
-
Sep 17, 2026, 14:51Konstantin Yenkoyan: Emicizumab and the Power of Translational Science
-
Sep 17, 2026, 14:47Zachary Sutton: Translating the 2026 KDIGO Guideline Into Practice
-
Sep 17, 2026, 14:43Leah Williams: Evaluating Medical Device Haemocompatibility Under ISO 10993-4
-
Sep 17, 2026, 14:32Ria Ahuja: Scaling Evidence-Informed Anemia Interventions Through Training
-
Sep 17, 2026, 14:23Neil Blumberg: ABO Nonidentical Transfusions and Mortality in Massive Transfusion